Previous studies have indicated that hypermethylation of the BNIP3 promoter was found in pancreatic cancer [18], and the BNIP3L gene was infrequently mutated in a panel of primary breast and ovarian tumors [19]. The gene discussed is BNIP3L; the disease is pancreatic neoplasm.